Received: 3 August 2018
Accepted: 19 November 2018
First Online: 19 December 2018
Ethics approval and consent to participate
: Undertaken as a retrospective audit of care provided within the region therefore no ethical approval required. Patient consent not required for purposes of audit as no intervention undertaken.
: No readily identifiable information published that would require individual consent.
: GG – no competing interests to declare.MFM – Novartis: Honorarium, speaker fee. Celgene: Speaker fee. Bristol Myer Squibb: Honorarium.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.